2023
DOI: 10.1007/s13304-023-01497-5
|View full text |Cite
|
Sign up to set email alerts
|

Facing adenocarcinoma of distal esophagus and esophagogastric junction: a CROSS versus FLOT propensity score-matched analysis of oncological outcomes in a high-volume institution

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 31 publications
0
1
0
Order By: Relevance
“…A recent retrospective study directly comparing FLOT vs CROSS shows similar 5-year overall survival in patients receiving FLOT and CROSS despite a higher pCR with CROSS [ 77 ]. Other recent smaller studies demonstrate similar survival patterns between CROSS and FLOT but show higher distant recurrence and postoperative respiratory failure with CROSS [ 78 , 79 ]. Results from the ESOPEC Phase III trial are eagerly awaited [ 44 ].…”
Section: Current Standard Of Care and Its Challengesmentioning
confidence: 79%
“…A recent retrospective study directly comparing FLOT vs CROSS shows similar 5-year overall survival in patients receiving FLOT and CROSS despite a higher pCR with CROSS [ 77 ]. Other recent smaller studies demonstrate similar survival patterns between CROSS and FLOT but show higher distant recurrence and postoperative respiratory failure with CROSS [ 78 , 79 ]. Results from the ESOPEC Phase III trial are eagerly awaited [ 44 ].…”
Section: Current Standard Of Care and Its Challengesmentioning
confidence: 79%